Navigation Links
VetNostic Laboratories® Announces New Testing for Dog Breeds
Date:10/27/2011

HAMILTON, N.J., Oct. 27, 2011 /PRNewswire/ -- VetNostic Laboratories® offers state-of-the-art genetic testing services for dog breeders and owners. Using DNA analysis, they are able to accurately and specifically determine whether or not a dog carries disease-causing genes. Providing reliable identification of these "carriers" ensures healthy litters and a successful breeding program. At this time, VetNostic Laboratories® is pleased to introduce two new tests to its growing diagnostic menu, Primary Lens Luxation and Greyhound Polyneuropathy.

Primary Lens Luxation (PLL) is a potentially blinding inherited disease in many Terrier breeds. It occurs when the ligaments holding the lens of the eye break down, causing it to dislocate. This can result in painful, teary, red eyes that may look hazy or cloudy. If not diagnosed and properly treated, PLL may lead to Uveitis and/or Glaucoma. This test is relevant to the following breeds: American Eskimo Dog, American Hairless (Rat) Terrier, Australian Cattle Dog, Chinese Crested, Chinese Foo Dog, Jack Russell Terrier, Jagd Terrier, Lakeland Terrier, Lancashire Heeler, Miniature Bull Terrier, Parson Russell Terrier, Rat Terrier, Russell Terrier, Sealyham Terrier, Teddy Roosevelt Terrier, Tenterfield Terrier, Tibetan Terrier, Toy Fox Terrier, Volpino Italiano, and Welsh Terrier.

Greyhound Polyneuropathy is a fatal neurological disease specific to the Greyhound show dog population. Symptoms include decreased or absent reflexes, muscle weakness, muscle pain and cramps, and a bunny-hopping gait. It usually appears within the first 9 months of age and then progresses so quickly that most affected dogs must be euthanized within their first year of life. Currently, there is no effective treatment for Greyhound Polyneuropathy.

VetNostic Laboratories® genetic tests for PLL and Greyhound Polyneuropathy can reliably identify dogs that are either clear, or possess one or two copies of the disease-causing genes which they may pass to their offspring. This clear, carrier, or affected result can help breeders determine which animals to include in their breeding programs.

Dr. Martin E. Adelson, Vice President of the Genesis Biotechology Group, stated, "We are pleased to continually add to the diversity of testing services offered by VetNostic Laboratories®. These most recent tests will help breeders to eliminate diseases such as PLL and Greyhound Polyneuropathy from future generations. This testing also provides true value to breeders as they can authenticate that their puppies are clear of common disorders caused by genetic mutations. It's an exciting time in the field of canine molecular diagnostics."

VetNostic Laboratories®, a division of Medical Diagnostic Laboratories, L.L.C., is a company within the Genesis Biotechnology Group. They are located in "Einstein's Alley," the research and technology corridor in Hamilton, New Jersey. Their facility is easily accessible in the New York, New Jersey, and Pennsylvania area.

VetNostic Laboratories® offers a web-based shopping cart to make molecular diagnostic testing readily available to the dog breeder and owner communities. Through this online ordering system, they are able to view test descriptions and order specimen collections kits. Specimen collection instructions and a "How-To" video facilitate step-by-step collection of cheek swabs from dogs.

To find out more, please visit http://www.vetnostic.com

Contact:

Rob Mason
Research Scientist
rmason@vetnostic.com
877.255.9208
http://www.vetnostic.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE VetNostic Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... This CAST literature review and report looks at problems ... on the economic effects in countries that are major global commodity exporters and importers, ... resultant risk of low level presence (LLP) puts large volumes of trade worth billions ...
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
(Date:12/8/2016)... , Dec. 8, 2016  Partnering to fuel ... Franklin Technology Partners of Southeastern Pennsylvania ... the parent company of Independence Blue Cross; and Safeguard ... their intentions for a $6 million funding initiative over ... startups. Responding to a burgeoning economic vitality ...
(Date:12/7/2016)... ... December 07, 2016 , ... A new study ... setting of previously treated, advanced pancreatic cancer, liquid biopsies are not yet an ... and timing of blood sampling may improve the value of a blood-based test.” ...
Breaking Biology Technology:
(Date:11/16/2016)... Sensory Inc ., a Silicon ... consumer electronics, and VeriTran , a technology ... today announced a global partnership that will provide ... users of mobile banking and mobile payments solutions.  ... which requires no specialized biometric scanners, yet provides ...
(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:11/14/2016)... , Nov. 14, 2016  Based ... identification market, Frost & Sullivan recognizes FST ... Sullivan Award for Visionary Innovation Leadership. FST ... the biometric identification market by pioneering In ... solution for instant, seamless, and non-invasive verification. ...
Breaking Biology News(10 mins):